Gilead sales propped up by COVID-19 drug Veklury
Bio Pharma Dive
FEBRUARY 5, 2021
Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere
Bio Pharma Dive
FEBRUARY 5, 2021
Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere
Bio Pharma Dive
FEBRUARY 2, 2021
The estimate for 2021 sales, which Pfizer splits with partner BioNTech, would make the vaccine one of the highest-selling medicines in the industry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JULY 31, 2020
Pfizer, Sanofi, GSK and Merck each reported lower vaccine sales as stay-at-home orders kept people from their regular vaccinations
Bio Pharma Dive
FEBRUARY 17, 2021
The Swiss drugmaker's pill Entresto is now cleared in the U.S. for use in patients with stronger hearts, expanding the eligible population by two-thirds
BioTech 365
FEBRUARY 23, 2021
LARVOL Appoints New Vice President, Global Sales LARVOL Appoints New Vice President, Global Sales SAN FRANCISCO–(BUSINESS WIRE)–LARVOL, leading provider of intelligence and data solutions to pharma and life science teams, today welcomes Mark Lagunowich as Vice President, Global Sales. “We
Pharma Mirror
FEBRUARY 25, 2021
Borja Guerra has been appointed new Sales & Service Director of Romaco Kilian in Cologne. The Romaco facilities in Bologna and Karlsruhe likewise have new Sales Directors: Massimiliano Cesarini and Ralph Augenstein.
BioTech 365
FEBRUARY 8, 2021
Eton Pharmaceuticals Announces Sale of Neurology Portfolio Eton Pharmaceuticals Announces Sale of Neurology Portfolio Eton to receive up to $45 million plus royalties on product sales DEER PARK, Ill., 08, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. Nasdaq: ETON), … Continue reading → GlobeNewswire
Bio Pharma Dive
OCTOBER 29, 2020
sales seem likely to slow in the months ahead Veklury, which was fully approved by the FDA last week, earned Gilead nearly $900 million in the third quarter, although U.S.
BioTech 365
MARCH 2, 2021
HealthEquity Announces Closing of Sale of Additional Shares HealthEquity Announces Closing of Sale of Additional Shares DRAPER, Utah, March 02, 2021 (GLOBE NEWSWIRE) — HealthEquity, Inc. NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering … Continue reading → GlobeNewswire
Bio Pharma Dive
OCTOBER 1, 2020
An 18-month investigation by the House Oversight Committee targeted the pricing practices behind the top-selling drugs Revlimid and Copaxone
BioTech 365
FEBRUARY 26, 2021
E-commerce sales rise by more than 74 percent to 433 million euros in Q1 2020/21 Q1 (Oct-Dec) Group sales of 1.2 billion euros despite hard lockdown in the core markets of Germany and France during Christmas business Q1 e-commerce share in … Continue reading → EQS Newsfeed
BioSpace
FEBRUARY 3, 2021
jobs, the majority of which are centered on the company’s sales team, according to a recent sales call Amgen is in the process of eliminating hundreds of U.S.
BioTech 365
FEBRUARY 22, 2021
Pure Extracts Submits Application to Health Canada for Sales License Pure Extracts Submits Application to Health Canada for Sales License VANCOUVER, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure … Continue reading → GlobeNewswire
BioTech 365
FEBRUARY 22, 2021
HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales On Track to Complete Business Combination with Vesper Healthcare in the First Half of 2021 MIAMI BEACH, Fla. &
BioTech 365
DECEMBER 30, 2020
Medicenna Establishes At-the-Market Sales Facility Medicenna Establishes At-the-Market Sales Facility TORONTO and HOUSTON, Dec. 30, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), a clinical stage immuno-oncology company, announced today that it has entered … Continue reading → GlobeNewswire
Pharma Phorum
AUGUST 24, 2020
Takeda Consumer Healthcare sells OTC medicines and other health products with sales of 60 billion yen ($567 million) in fiscal 2019. It also comes after chief executive Christophe Weber said the sale of the consumer health unit was “unlikely” last year.
Pharma Phorum
SEPTEMBER 22, 2020
Life sciences commercial organizations can now forecast sales, predict churn, analyze brand propensity and launch new products with BirdzAI . P360 , a leading developer of technology for life sciences companies, today announced major updates to its sales enablement platform BirdzAI.
BioTech 365
JANUARY 31, 2021
Takeda Completes Sale of TachoSil® to Corza Health Takeda Completes Sale of TachoSil® to Corza Health OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch (“TachoSil®”) … Continue reading → Business Wire
BioTech 365
NOVEMBER 4, 2020
SHINE Announces First Sales of Its Non-carrier-added Lutetium-177 SHINE Announces First Sales of Its Non-carrier-added Lutetium-177 JANESVILLE, Wis.–(BUSINESS
Pharma Times
JULY 30, 2020
Sales decline in the second quarter reflects expected disruption from COVID-19
BioSpace
FEBRUARY 3, 2021
Not every biotech job is heavily rooted in science. Some rely on additional skills, like those of communication, organization and more in order to play a crucial role in the industry
Bio Pharma Dive
OCTOBER 21, 2020
Under a deal reached with the Department of Justice, Purdue faces fines and a forfeiture worth more than $5 billion — the largest penalties ever for a drug company
BioTech 365
JANUARY 4, 2021
Takeda Completes Sale of Select Non-Core Assets to Cheplapharm Takeda Completes Sale of Select Non-Core Assets to Cheplapharm OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select prescription … Continue reading → Business Wire
BioTech 365
FEBRUARY 9, 2021
Pharma Phorum
OCTOBER 29, 2020
billion at a time when most other pharma companies have seen sales growth pegged back by restricted access to healthcare during pandemic lockdowns. The bulk of the Veklury sales ($785 million) were in the US, with Europe accounting for a sizeable chunk of the remainder. The post Gilead Q3 revenue rise bolstered by $873m Veklury sales appeared first on. News Sales and Marketing coronavirus COVID-19 Financial Gilead Sciences remdesivir Veklury
BioTech 365
FEBRUARY 8, 2021
on Sale to Proud Moments ABA Edgemont Partners Advises Bridges Inc. Edgemont Partners Advises Bridges Inc.
XTalks
MARCH 1, 2021
Anti-inflammatory drugs like Restasis and Xiidra are popular treatment options for the condition, but will the emergence of mask-associated dry eye bolster their sales? The post Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales appeared first on Xtalks.
Pharma Phorum
NOVEMBER 3, 2020
Lundbeck posted quarterly sales of 4.46 The performance was thanks to increased sales of its mental health drug Abilify Maintena, which increased 19% in the first nine months of the year compared with the same period last year to 1.729 billion Danish kroner ($270 million).
BioTech 365
FEBRUARY 22, 2021
United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 – ResearchAndMarkets.com United States HIV Infection Drug Market, Dosage, Price, Sales Insight Report 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 … Continue reading → Business Wire
BioTech 365
MARCH 4, 2021
COLTENE Holding AG / Key word(s): Annual Results 05-March-2021 / 06:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is solely responsible for the content of this announcement. Due to global COVID-19 pandemic, net … Continue reading → EQS Newsfeed
Pharma Phorum
OCTOBER 20, 2020
Huge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Dutch health technology group reported sales of €4.98bn, a 10% year-over-year growth. Sales were down 3%, to €1.97bn compared to a 9% dip in Q2.
The Pharma Data
DECEMBER 29, 2020
Shapiro as Vice President of Sales, effective January 1, 2021. a Women’s Health Company which manufactures patented CMRF Technology, where he recruited a sales team which generated approximately $11 million in revenue in the year of launch. .
BioTech 365
JANUARY 21, 2021
HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel DENVER–(BUSINESS WIRE)–$CBD.U #CBD–HempFusion
BioTech 365
DECEMBER 30, 2020
EDAP Announces End of the Year Focal One® Sales EDAP Announces End of the Year Focal One® Sales Among December deals closed, two major US institutions have purchased Focal One University of California, San Francisco Medical Center and Cleveland Clinic … Continue reading → GlobeNewswire
BioTech 365
DECEMBER 28, 2020
Y-mAbs Announces Sale of Priority Review Voucher Y-mAbs Announces Sale of Priority Review Voucher NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical company focused on the development and … Continue reading → GlobeNewswire
BioTech 365
DECEMBER 18, 2020
LUM001 Insight and Market Sales Forecast Report 2020-2030 – ResearchAndMarkets.com LUM001 Insight and Market Sales Forecast Report 2020-2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “LUM001 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.
Pharma Phorum
OCTOBER 27, 2020
Novartis’ pharmaceutical sales recovered in the third quarter of this year after an earlier COVID-19 decline, as new drugs like gene therapy Zolgensma gathered pace. . Correcting for currency fluctuations, net sales were flat at $12.3
BioTech 365
MARCH 1, 2021
Press Release Medios AG achieves 2020 annual targets – sales expected to almost double in 2021 … Continue reading → EQS NewsfeedDGAP-News: Medios AG / Key word(s): Preliminary Results/Change in Forecast 01.03.2021 / 11:30 The issuer is solely responsible for the content of this announcement.
BioTech 365
JANUARY 14, 2021
R-Zero Poised to be a Breakthrough Leader in Enterprise Biosafety with Record Sales in First Year R-Zero Poised to be a Breakthrough Leader in Enterprise Biosafety with Record Sales in First Year Millions in Sales Booked Within Just Three Months … Continue reading → Business Wire
BioTech 365
NOVEMBER 12, 2020
A Successful Rights Issue with Focus on Sales! A Successful Rights Issue with Focus on Sales! Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Successful Rights Issue with Focus on … Continue reading → GlobeNewswire
Scienmag
NOVEMBER 19, 2020
News from the Journal of Marketing Researchers from Temple University, Sichuan University, and Fudan University published a new paper in the Journal of Marketing that explores the growing use of AI to coach sales agents to determine if there are any caveats that inhibit the effective use of this technology.
BioTech 365
FEBRUARY 9, 2021
Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies … Continue reading → GlobeNewswire
Let's personalize your content